Tolemy Bio operates as an AI-native virtual cell platform focused on accelerating therapeutic development and manufacture. By simulating cell biology, the company constructs an intelligence layer designed to direct cellular systems for superior therapeutic outcomes. Their technology treats living cells as key therapeutic tools, utilizing artificial intelligence to enhance the design of future medicines. The platform seeks partnerships across cell biology, advanced therapeutics, and bioprocessing sectors. Serving pharmaceutical and biotech industries rather than individual patients, Tolemy positions itself as a critical infrastructure tool for modernizing medicine development and production.